Can ancient chinese medicine predict lung cancer drug success?

NCT ID NCT07338396

Not yet recruiting Knowledge-focused Sponsor: Guangzhou University of Traditional Chinese Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how Traditional Chinese Medicine (TCM) body patterns, like tongue and pulse readings, relate to how well targeted lung cancer drugs work. About 3000 people with a specific type of lung cancer will be followed for up to 5 years. Researchers will collect TCM information and samples to find links between these patterns and treatment outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER (NSCLC)

Contacts and locations

Locations

Affiliated Hospital of Xinxiang Medical University, Henan province

Weihui, Henan, China
Beijing chest Hospital

Beijing, Beijing Municipality, 100000, China
Guang'anmen Hospital of china Academy of chinese Medical Sciences

Beijing, Beijing Municipality, 100000, China
Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou, Guangdong, 510000, China
Sichuan Cancer Hospital and Research Institute

Chengdu, Sichuan, 610040, China
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine

Shanghai, Shanghai Municipality, 200437, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.